Unlock the Editor’s Digest at no cost
Roula Khalaf, Editor of the FT, selects her favorite tales on this weekly publication.
AstraZeneca has stated a “small quantity” of its workers are below investigation in China.
The affirmation got here after Bloomberg reported on Thursday that police had been investigating 5 present and former AstraZeneca workers over infringement of information privateness legal guidelines and importing an unlicensed drugs.
The drugmaker didn’t present any additional info.
Based on Bloomberg, the workers are Chinese language residents who marketed most cancers medicine for AstraZeneca and are being investigated over the gathering of affected person knowledge and the distribution of a drug that had not been accepted.
The corporate has a big presence in China and has invested in growing unbiased provide chains within the nation. It reported $5.9bn of income from China in 2023, which was 13 per cent of whole gross sales.
